MANUFACTURERS LIFE INSURANCE COMPANY, THE - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 89 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$208,000
-10.3%
3,9350.0%0.00%
Q2 2020$232,000
-2.5%
3,935
-6.6%
0.00%
Q1 2020$238,000
-80.8%
4,212
-80.6%
0.00%
-100.0%
Q4 2019$1,238,000
+3.5%
21,737
-0.5%
0.00%0.0%
Q3 2019$1,196,000
+388.2%
21,839
+432.1%
0.00%
Q2 2019$245,000
+1.7%
4,104
-23.7%
0.00%
Q2 2018$241,000
+12.1%
5,380
+10.8%
0.00%
Q1 2018$215,000
+4.4%
4,856
+2.5%
0.00%
Q4 2017$206,000
-6.8%
4,739
-0.4%
0.00%
Q3 2017$221,000
-9.4%
4,760
-3.3%
0.00%
Q2 2017$244,000
-1.2%
4,920
+9.1%
0.00%
Q1 2017$247,000
+6.9%
4,510
+8.4%
0.00%
Q4 2016$231,000
+17.3%
4,159
-3.7%
0.00%
Q3 2016$197,000
+20.1%
4,317
+5.3%
0.00%
Q2 2016$164,000
+42.6%
4,098
+23.2%
0.00%
Q1 2016$115,000
-21.2%
3,326
-2.1%
0.00%
Q4 2015$146,000
+0.7%
3,398
+2.0%
0.00%
Q3 2015$145,000
-15.7%
3,3310.0%0.00%
Q2 2015$172,000
+177.4%
3,331
+109.5%
0.00%
Q1 2015$62,0000.0%1,590
-0.9%
0.00%
Q4 2014$62,000
+51.2%
1,604
+37.1%
0.00%
Q3 2014$41,000
+485.7%
1,170
+348.3%
0.00%
Q2 2014$7,000
-12.5%
261
-16.6%
0.00%
Q1 2014$8,000
+60.0%
313
+46.9%
0.00%
Q4 2013$5,0000.0%213
-23.7%
0.00%
Q3 2013$5,000
+25.0%
2790.0%0.00%
Q2 2013$4,0002790.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2017
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders